| Website | abcellute.com |
| Category | BioTech |
| Phone | 029-20-76-50-80 |
| enquiries@abcellu... | |
| Employees | |
| Founded | 2001 |
| TOTAL | $806k |
| FUNDING TOTAL | $806k |
| Venture Round, 9/07 Fusion IP Finance Wales | £400k |
Abcellute is to achieve global adoption of its SureCellâ„¢ cell transport technology by providing the research community with enhanced, fresh-cell systems. These will maximise the utilisation of this often scarce resource and provide products that are much more convenient to use than current fresh-cell systems. This will deliver benefits to biomedical researchers in key areas such as pre-clinical drug evaluation and regenerative medicine.